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ABSTRACT
Objective: To re-examine proposed models of cognitive test performance that concluded separate
factor structures were required for people with Alzheimer disease (AD) and older adults without
dementia.
Methods: Five models of cognitive test performance were compared using multistep confirmatory
factor analysis in 115 individuals with autopsy-confirmed AD and 191 research participants
without clinical dementia from longitudinal studies at the Washington University AD Research
Center. The models were then cross-validated using independent samples of 323 people with
clinically diagnosed dementia of the Alzheimer type and 212 cognitively healthy older adults.
Results: After controlling for Alzheimer-specific changes in episodic memory, performance on the
battery of tests used here was best represented in people both with and without dementia by a
single model of one general factor and three specific factors (verbal memory, visuospatial ability,
and working memory). Performance by people with dementia was lower on the general factor than
it was by those without dementia. Larger variances associated with the specific factors in the
group with dementia indicated greater individual differences in the pattern of cognitive deficits in
the stage of AD.
Conclusions: A hybrid model of general and specific cognitive domains simplifies cognitive re-
search by allowing direct comparison of normal aging and Alzheimer disease performance. The
presence of a general factor maximizes detection of the dementia, whereas the specific fac-
tors reveal the heterogeneity of dementia’s associated cognitive deficits. Neurology® 2008;
71:1783–1789
GLOSSARY
AD  Alzheimer disease; BD  Block Design; BNT  Boston Naming Test; BVRT  Benton Visual Retention Test; CDR 
Clinical Dementia Rating; CFA  confirmatory factor analysis; CFI  comparative fit index; DAT  dementia of the Alzheimer
type; DS-B  Digit Span Backward; DS-F  Digit Span Forward; DSym  Digit Symbol; INFO  information; LBs  Lewy
bodies; LM  Logical Memory; MC  Mental Control; NIA  National Institute on Aging; PA  Paired Associate Learning;
RMSEA  root mean square error of approximation; TOI  tests of invariance; TRA  Trailmaking A; WF  Word Fluency.
We previously reported that cognitive test performance in individuals with and without de-
mentia is best characterized by two distinct factor structures: a single general factor for individ-
uals without dementia compared with three orthogonal factors representing verbal memory,
visuospatial, and working memory in dementia of the Alzheimer type (DAT).1 Other reports
using similar exploratory techniques report separate factors (indicating that DAT affects differ-
ent aspects of cognition independently2-4), or a global deficit that produces a single general
factor.5,6 This discrepancy makes it difficult to know how best to compare and contrast decre-
ments in cognitive performance between different patient populations.
Confirmatory factor analysis (CFA) provides the ability to test competing models (i.e.,
general vs multiple factors) either within a single population or across multiple populations.
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Previous efforts using CFA in DAT support a
multifactor hypothesis of cognitive deficits.7-9
Two CFA studies have compared individuals
with and without dementia. One report con-
cluded a general factor was sufficient for peo-
ple with and without dementia,10 while the
other reported a multifactor fit for the two
groups.11 There were a number of differences
in the samples, measures, and statistical mod-
els used in the two studies that may have con-
tributed to the discrepancy. In addition, the
groups with dementia in these reports did not
include autopsy-confirmed cases to exclude
competing causes of dementia. In the current
report we used a multigroup confirmatory
process to investigate the presence of both
multiple domains of cognition and a general
factor common to participants without de-
mentia and those with autopsy-confirmed
Alzheimer disease (AD).
METHODS Participants. Archival data from four indepen-
dent groups of participants (two DAT, two controls without
dementia) were selected from volunteers enrolled in a longitudi-
nal study of healthy aging and dementia. Sample 1 with demen-
tia included all individuals with autopsy confirmation of AD
(n  115) without other pathology that could cause dementia
enrolled from 1997 through March 2005. All autopsy confirmed
individuals included here also received a clinical diagnosis of
CDR 0.5 (n  17) or greater (n  98) in life. On average the
interval between death and these participants’ last time of assess-
ment was 1.5 years. Sample 2 with dementia (n  363) included
individuals with clinical diagnoses of DAT enrolled prior to
1997 and includes individuals reported previously.1 Sample 1
without dementia (n  191) was also enrolled between 1997
and March 2005. Sample 2 without dementia (n  212) was
enrolled prior to 1997 and includes individuals reported previ-
ously.1 The Washington University Human Studies Committee
approved all procedures.
Clinical evaluation. Experienced clinicians conducted semi-
structured interviews with the participant and a knowledgeable
collateral source (usually a spouse or adult child) at an initial visit
and annually thereafter. The Clinical Dementia Rating (CDR)
was used to determine the presence or absence of dementia and,
if present, stage its severity.12 The CDR evaluates cognitive func-
tion in each of six categories (memory, orientation, judgment
and problem solving, performance in community affairs, home
and hobbies, and personal care) without reference to psychomet-
ric performance or results of previous evaluations. CDR 0 indi-
cates no dementia, and CDR 0.5, 1, 2, or 3 correspond to very
mild, mild, moderate, and severe dementia.
The CDR has high interrater reliability,13 is sensitive to clin-
ical progression, and is highly predictive (93%) of autopsy-
confirmed AD.14 The clinical diagnostic criteria for DAT used
for this study are consistent with probable AD according to the
National Institute of Neurological and Communicative Disor-
ders and Stroke and AD and Related Disorders Association.15
Individuals with a CDR greater than 0 but clinical diagnoses of
dementias other than DAT were excluded. Individuals with de-
mentia with an initial CDR of 2 or greater were also excluded as
these individuals often have difficulty completing psychometric
assessment.
Neuropsychological assessment. A 90-minute battery was
administered annually to all participants approximately 2 weeks
after clinical evaluation. This battery tests across multiple cogni-
tive domains (i.e., semantic memory, episodic memory, working
memory, and visuospatial ability). Tests include Informa-
tion,16 Associate Learning,17 Boston Naming Test,18 Logical
Memory,17 Benton Visual Retention Test: Form D-Copy,19
Digit Symbol,16 Trailmaking A,20 Block Design,16 Word Flu-
ency for S and P,21 Mental Control,17 Digit Span Forward and
Backward.17 Psychometricians were not informed of the re-
sults of the clinical evaluation.
Psychometric data from a single time of measurement were
used for each participant. For those without dementia the first
time of assessment was used provided that the CDR was also 0 at
the following two assessments; otherwise the participant was ex-
cluded so as to eliminate people who potentially had a preclinical
dementia. The data from the groups with dementia used in the
analyses were from a time of assessment when participants had
mild dementia (either their last CDR 0.5 or their first CDR 1).
Prior to conducting the CFA all psychometric measures were
standardized to z scores (collapsed over the four samples) and
Trailmaking A was reversed scored so that a high score on all
variables indicated good performance. Because age varied across
patient types, age at time of assessment was regressed on every
subtest and CFAs were conducted using these age-corrected re-
siduals.
Neuropathology. All brains were examined with a standard
protocol.22 Following fixation in neutral buffered 10% formalin,
tissue blocks were taken from 30 brain regions. Sections (6 m)
from paraffin-embedded tissue blocks were stained with
hematoxylin-eosin, Gallyas and modified Bielschowsky silver
stains, and immunohistochemical methods.22 Histologic criteria
for AD were based on quantification of diffuse and neuritic amy-
loid deposition in five cortical regions with 10 mm2 microscopic
fields in each region22 as well as National Institute on Aging
(NIA)-Reagan23 neuropathologic probability estimates of AD.
The two sets of criteria have excellent agreement for intermediate
and high probability of AD. Cases were screened for Lewy bodies
(LBs) with antibodies to alpha-synuclein and were also examined
for the presence of cortical and subcortical infarcts and hemor-
rhages to exclude confounding dementia diagnoses. It was im-
portant for the validation sample to only be composed of cases with
“pure” AD. The presence of any other neuropathology was exclu-
sionary for this study. Thus, the AD group did not contain any LBs
(neocortical, amygdala, or brainstem) or vascular lesions.
Statistical analyses. CFA (AMOS v7.0, SPSS Inc., Chicago,
IL) was conducted in a multistep process. First the relative fit of
four candidate hypothetical models (figure 1) based on previous
studies was examined to determine domain content, factor load-
ings, and factor interrelationships. Model A hypothesized a sin-
gle general factor. Model B tested the hypothesis that was three
independent factors. Model C allowed the three factors to be
correlated. A hybrid Model D allowed both three specific factors
and a general first-order factor. Its purpose was to determine if a
single model would satisfactorily represent performances by peo-
ple with and without dementia. The factor analyses used a direct
estimation approach based on a full information maximum like-
lihood algorithm to deal with missing data.
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The empirical validity of each theoretical model (i.e., how
well it fit the observed data) was assessed using goodness-of-fit
indices.24 Model selection was primarily based on differences in
the root mean square error of approximation (RMSEA25), which
is a measure of discrepancy between predicted and observed
model values; values closer to 0 indicate better fit (preferred val-
ues  0.09). In accordance with more recent guidelines, better
fitting models were accepted when the change in the RMSEA
(RMSEA) was greater than 0.02.26 To provide a basis for com-
parison of current results with CFA indices used in other reports
the log likelihood ratio test statistic (-2LL; smaller values indicate
better fit) and the comparative fit index (CFI, values closer to 1
indicate better fit) were also calculated. Then we evaluated criti-
cal ratios (the ratio of an estimated parameter to its standard
error) to refine the selected model for each group.27 This statistic
indicates the relative contribution of a particular model parame-
ter to the overall fit of the model. We only evaluated covariances,
first among subtests and then among factors. Only when a co-
variance parameter was both theoretically motivated and pro-
duced a significant improvement to model fit (critical ratio 
1.96 and RMSEA  0.02) was it adopted.
Next we used tests of invariance (TOI) to compare independent
samples of the same patient group (i.e., sample 1 without dementia
vs sample 2 without dementia; sample 1 with dementia vs sample 2
with dementia). TOI use a series of increasingly restrictive models to
investigate how samples differ in factor structure and variance-
covariance patterns. We began with tests of strong factorial invari-
ance; both samples should have the same factor structure, the same
factor loadings, and the same indicator intercepts (i.e., observed
measures should have the same Y intercept in the two samples when
the latent variable is 0). The next constraint added was the require-
ment of equal factor means. The final and most restrictive model
added the requirements of equal factor variances and equal covari-
ances among the factors. Lower models must be accepted before
subsequent higher order solutions can be interpreted. The level at
which the model fails to fit defines how the groups differ. Finally, we
again used TOI to compare people with and without dementia. In
this step we did not expect concordance across all levels of the
model. We anticipated good fit at the measurement level, but poor
fit was expected at higher levels. For example, the group with de-
mentia should have lower factor means than the group without de-
mentia. We did not make any predictions about the equality of the
factor variances or the correlations among the specific factors across
the two populations.
RESULTS Sample characteristics. Demographic in-
formation and neuropsychological measures for each
of the four groups are shown in table 1. The four
groups were similar with respect to age and education
except that the autopsy-confirmed AD group was
older (t  4.17, p  0.001). Subtest comparisons
within a similar clinical status were all nonsignificant
with Bonferroni correction (all t  2.38). All partic-
ipants spoke English and lived in the greater St.
Louis metropolitan area; 24 were African American,
and the remainder were Caucasian.
Comparison of models. As shown in table 2 and fig-
ure 2, Model D was the best-fitting candidate model
for sample 1 without dementia (RMSEA  0.04;
2LL  51.4; CFI  0.98). A general first-order
factor and three correlated specific factors labeled
Verbal Memory, Visuospatial Construction, and
Working Memory are depicted in figure 2A with cor-
responding factor loadings of the 12 measures. The
correlations among the three specific factors were
0.64, 0.60, and 0.28. Model D also provided a bor-
derline acceptable fit for sample 1 with dementia
Figure 1 Relative fit of four candidate hypothetical models
Models were tested with confirmatory factor analyses based on previous studies was ex-
amined to determine domain content, factor loadings, and factor interrelationships. Model
D was found to best describe cognitive abilities in samples with and without dementia. See
text for complete details. INFO  information; PA  Paired Associate Learning; BNT  Bos-
ton Naming Test; LM  Logical Memory; BVRT  Benton Visual Retention Test; DSym 
Digit Symbol; TRA  Trailmaking A; BD  Block Design; WF  Word Fluency; MC  Mental
Control; DS-B  Digit Span Backward; DS-F  Digit Span Forward.
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(RMSEA  0.09), although not better than Model
C (three correlated specific factors), which also had a
RMSEA of 0.09.
Because Model D provided the best fit for both
the groups with and without dementia, we desig-
nated it as the new baseline model and used stan-
dard procedures of model respecification28 to
assess whether any further model refinements
would improve fit. Candidate respecifications
were identified using critical ratios and accepted
only if theoretically motivated and they resulted in
significant improvement in overall model fit.26
Changes to Model D did not improve goodness-
of-fit for the group without dementia. In the
group with dementia, however, there was a high
degree of correlation between the errors of the two
tests of episodic memory (Logical Memory and As-
sociate Learning; CR  5.27). Allowing this additional
error covariance in Model E (figure 2B) significantly
improved the fit in group with dementia (RMSEA 
0.05; -2LL  52.5; CFI  0.98).
Cross-validation. Samples 1 and 2 of the participants
without dementia and then samples 1 and 2 of the
participants with dementia were compared to deter-
mine if the model configuration functioned similarly
in independent samples from the same population.
Model D was replicated in the samples without de-
mentia at all levels of restriction (RMSEA  0.05;
RMSEA  0; 2LL  229.7; CFI  0.92).
Model E was similarly replicated at all levels of re-
striction in the samples with dementia (RMSEA 
0.04; RMSEA  0; 2LL  223.0; CFI  0.96).
Comparison of individuals with vs without dementia.
As shown in table 3 and (figure 2), Model D and E
were equivalent at the measurement level (RMSEA 
0.05; 2LL  196.4; CFI  0.93). The underlying
constructs represented in Model D and Model E are the
same for the groups with and without dementia. The
factor loadings shown in Model D (figure 2A) did not
differ from those observed for the group with dementia
in Model E (figure 2B); the individual tests have the
same relation to the four factors in people with and
without dementia. The two models are equivalent in
terms of factor means (RMSEA  0.09)25 but not using
more recent guidelines (RMSEA  0.02).26 The esti-
mated means and standard deviations of the group
without dementia served as the reference and were set to
0 and 1. For the sample with dementia, their mean on
the general factor was significantly lower (2.17) and
Table 2 Results (root mean square error of approximation and 90% CI) of
confirmatory analyses testing hypothetical models within groups
Model
Sample 1 without
dementia
Sample 1 with
Alzheimer disease
A (one factor) 0.10 (0.09–0.12) 0.17 (0.15–0.19)
B (three independent factors) 0.14 (0.12–0.16) 0.14 (0.12–0.17)
C (three correlated factors) 0.07 (0.05–0.09) 0.09 (0.06–0.12)
D (three specific, one general) 0.04 (0.00–0.07) 0.09 (0.06–0.12)
E (three specific, one general)* 0.05 (0.00–0.08)
*Allows correlation between residuals for Logical Memory and Associate Learning.
Table 1 Demographic description of four samples
Without dementia With dementia
Sample 1 (n  191) Sample 2 (n  212) Sample 1 (AD) (n  115) Sample 2 (DAT) (n  363)
Age, y 74.4 (9.4) 74.9 (10.3) 80.6 (11.0) 76.6 (8.8)
Education, y 14.7 (3.0) 13.8 (3.2) 13.9 (3.4) 12.6 (3.6)
Gender (% men) 39 34 47 41
Logical Memory 8.73 (2.99) 8.10 (2.82) 3.11 (2.62) 2.84 (2.72)
Information 20.38 (4.34) 19.75 (4.49) 13.25 (5.76) 11.62 (6.08)
Boston Naming 54.27 (5.32) 52.98 (7.11) 40.11 (12.42) 36.44 (14.57)
Associate Learning 13.83 (3.42) 12.48 (3.42) 7.69 (3.31) 6.95 (3.52)
Trailmaking A (sec)* 42.04 (20.14) 48.78 (25.04) 91.42 (48.72) 93.16 (49.45)
Block Design 29.22 (8.98) 28.94 (8.53) 16.65 (10.81) 16.33 (10.53)
Benton (copy) 9.69 (0.82) 9.42 (1.08) 8.09 (2.67) 7.93 (2.42)
Digit Symbol 45.24 (10.02) 43.06 (12.88) 22.78 (14.35) 22.54 (14.45)
Mental Control 7.22 (1.73) 7.17 (1.89) 5.14 (2.54) 5.06 (2.69)
Digits Forward 6.37 (1.25) 6.67 (1.14) 5.77 (1.30) 5.95 (1.32)
Digits Backward 4.61 (1.24) 4.84 (1.31) 3.56 (1.34) 3.54 (1.53)
Word Fluency (S & P) 29.29 (9.84) 28.46 (9.86) 18.70 (9.76) 17.78 (10.48)
Values are mean (SD).
*High scores indicate poor performance.
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the SD was slightly larger (1.19) than seen in samples
without dementia, but no significant mean differences
were found regarding the three specific factors. The
only difference in the specific factors was the correlation
between the three specific factors was between Verbal
Memory and Working Memory (0.28 in group with-
out dementia vs 0.44 in group with dementia).
DISCUSSION A hybrid model made up of three
specific factors and one general factor best character-
izes the underlying cognitive structure in individuals
with and without dementia. This was cross-validated
in a larger independent sample. These findings per-
mit accurate characterization of cognitive perfor-
mance. The hybrid model combination of general
and specific factors is consistent with findings that
intellectual ability can best be described both as a
general score and by specific mental abilities.23,24 The
added complexity of the hybrid model accounted for
more variance in the data and left less unexplained
variance in the residual. This hybrid model resolves
the conflicting results present in the literature2-9 and
eliminates the necessity of allowing different factor
structures for people with and without AD.
Models for the groups with and without dementia
Figure 2 Results of between-group tests of invariance (TOI) to compare independent samples
(A) Confirmatory factor analysis (CFA) model of cognitive performance in older adults without dementia (sample 1). (B)
Slight modification of the CFA model of cognitive performance in individuals with mild Alzheimer disease (autopsy con-
firmed sample) by allowing the errors in Logical Memory and Associate Learning to correlate. Loadings are identical across
figures. INFO  information; PA  Paired Associate Learning; BNT  Boston Naming Test; LM  Logical Memory; BVRT  Benton
Visual Retention Test; DSym  Digit Symbol; TRA  Trailmaking A; BD  Block Design; WF  Word Fluency; MC  Mental
Control; DS-B  Digit Span Backward; DS-F  Digit Span Forward.
Table 3 Results (root mean square error of approximation and 90% CI) of cross-validation (sample 1 vs
sample 2) multigroup confirmatory factor analyses and comparison of groups with and without
dementia from sample 1
Restrictions
Samples 1 vs 2
without dementia
(Model D)
Samples 1 vs 2
with dementia
(Model E)
Sample 1 without
dementia vs Alzheimer
disease (Models D vs E)
Strong factorial invariance 0.05 (0.04–0.06) 0.04 (0.03–0.05) 0.05 (0.04–0.06)
Equal factor means 0.05 (0.04–0.06) 0.04 (0.04–0.05) 0.08 (0.07–0.09)
Equal factor variances and correlations 0.05 (0.04–0.06) 0.04 (0.04–0.05) 0.09 (0.08–0.10)
Equal number of factors, factor loadings, and indicator intercepts.
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differed in that the two episodic memory tasks (Log-
ical Memory and Associate Learning) were correlated
in the group with dementia (Model E) but not in the
group without dementia (Model D). This same pat-
tern was found across validation samples. Tasks re-
quiring effortful verbal encoding and immediate
recall are preferentially affected by AD29,30 and vari-
ability in these scores reflect an episodic memory spe-
cific degradation in this disease process.
There was a second, more general effect of de-
mentia reflected by the lower estimated mean for the
general factor score in the group with dementia but
not in the three specific factor means. The opposite
was true for factor variances. AD variability was sig-
nificantly larger for the specific factors compared
with only a slight increase in variance in the general
domain. Thus performance on the specific factors
was poor for some people, but not all. These results
converge with the hypothesis that the AD process is
multifactorial and may have differential effects vary-
ing by individual as well as the stage of the disease.7-9
This heterogeneity suggests that within the observed
overall cognitive decline in AD there may exist dis-
crete decrement profiles that mask one another when
measured together. In addition to increased variance
in the specific cognitive domains in AD, there was
also a changed pattern of covariance between cogni-
tive domains. Verbal memory ability was more
strongly related to working memory. This is consis-
tent with the observation that episodic and semantic
memory deficits in AD reflect deceased working
memory buffer size and efficiency.31
This study has both strengths and limitations.
Clinical diagnoses were rendered by history, neuro-
logic examination, and clinical interview, indepen-
dent of neuropsychological test scores. This permitted us
to avoid circularity when neuropsychological data are
used for both classification of cases as well as an out-
come measure. Although the test battery is broad in
scope, it was originally designed 30 years ago at the
start of the longitudinal study and therefore did not
include more modern measures of attention, execu-
tive function, and working memory. It is possible
that the inclusion of sufficient measures of these
other cognitive domains may reveal more than the
three specific domains reported here.
There is disagreement about what constitutes suf-
ficient sample size for CFA, especially in clinical re-
search where data collection is intensive and sample
size often limited. Although larger sample sizes than
those presented here are commonly used, recent
modeling work32 indicates that sample size is condi-
tional on data and model characteristics. Good-
fitting models can be identified with relatively
smaller sample sizes when reliable measures are used.
The sample 1 sizes (115 and 191) proved adequate
consistent with Monte Carlo studies demonstrating
that fit indices are sufficiently powered when sample
size is greater than 100.33
The strengths of the study include the use of well-
characterized longitudinal samples of participants to
generate initial findings followed by replication of
findings in a second independent set of well-
characterized participants with similar diagnoses.
The samples without dementia represent older adults
who remained dementia free for at least two more
assessments, lessening the possibility of misclassifica-
tion. Likewise the sample with dementia is drawn
from individuals with antemortem diagnoses of
DAT and autopsy confirmation of AD, free from
other pathologies (Lewy bodies, vascular lesions) that
may influence cognitive performance.
This hybrid CFA model now allows us to explore
clinical and cognitive performance across diverse
clinical samples and eliminates the necessity of allow-
ing unique factor structures for people with and
without dementia. A second benefit of these models
is that now we are able to perform comparisons of
cognitive abilities between different neurodegenera-
tive disorders (e.g., AD vs PD) using a common neu-
ropsychological test battery. Since the tests used in
our battery are similar to those in the Uniform Data
Set34 neuropsychological battery for the National In-
stitute on Aging AD Center Program, we may be
able to apply similarly structured models (i.e., hy-
bridized specific and general factors) to other re-
search samples provided that the cognitive domains
assessed are similar to the ones measured here.
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